Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2008
02/19/2008US7332169 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine
02/19/2008US7332167 Diagnosis of chronic infections by Candida albicans
02/19/2008US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
02/19/2008CA2423294C Method for synthesising peptides, peptide mimetics and proteins
02/19/2008CA2379205C Cationic block copolymers
02/19/2008CA2328423C Amino acid modified polypeptides
02/19/2008CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide
02/19/2008CA2253287C A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
02/19/2008CA2245675C Engineering affinity ligands for macromolecules
02/19/2008CA2220008C Composition and method for tumor imaging
02/19/2008CA2209858C Il-2r-associated polypeptide and dna molecules coding therefor
02/19/2008CA2205175C A polynucleotide tuberculosis vaccine
02/19/2008CA2186592C Alkaline bacillus amylase
02/19/2008CA2171699C Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
02/19/2008CA2143621C Horseshoe crab amebocyte lysate factor g subunit a and dna encoding thereof
02/19/2008CA2121364C Vaccines for actinobacillus pleuropneumoniae
02/19/2008CA2077896C Plant desaturases - compositions and uses
02/19/2008CA1341567C Dna sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
02/18/2008CA2596238A1 Compositions and methods for detecting cancer
02/15/2008CA2554500A1 West nile virus antigent and assay
02/14/2008WO2008019368A2 Albumin-insulin fusion proteins
02/14/2008WO2008019290A2 Human antibodies to erbb 2
02/14/2008WO2008019142A2 Oligonucleotide systems for targeted intracellular delivery
02/14/2008WO2008018795A1 Methods and means for treating dna repeat instability associated genetic disorders
02/14/2008WO2008018790A2 Quality control of agricultural products based on gene expression
02/14/2008WO2008018789A2 Methods and means for diagnosing and treatment of osteoarthritis
02/14/2008WO2008018640A1 Plasmid, transformant, and method for production of 3-carboxymuconolactone
02/14/2008WO2008018625A2 Prostate cancer related gene styk1
02/14/2008WO2008018562A1 Production of useful protein such as antibody having modified sugar chain in egg yolk of transgenic chicken
02/14/2008WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF
02/14/2008WO2008018542A1 Gene polymorphism useful for assistance/therapy for smoking cessation
02/14/2008WO2008018517A1 Therapeutic and/or preventive agent for disease accompanied by cell overgrowth, and polynucleotide useful as the active ingredient
02/14/2008WO2008018488A1 Antibacterial agent
02/14/2008WO2008018472A1 Novel monoclonal antibody and use of the same
02/14/2008WO2008018469A1 Method for production of pcr amplification product and use thereof
02/14/2008WO2008018305A1 Method of detecting variation and kit to be used therein
02/14/2008WO2008018240A1 Homozygote haplotype method
02/14/2008WO2008017906A1 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins
02/14/2008WO2008017706A1 Method of increasing resistance against soybean rust in transgenic plants
02/14/2008WO2008017692A2 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
02/14/2008WO2008017646A2 Expression of genes from gram negative bacteria in fungi
02/14/2008WO2008017636A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof
02/14/2008WO2008017598A2 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon
02/14/2008WO2008017568A1 Plasmids with immunological action
02/14/2008WO2008017518A1 Genetically modified plants which synthesize a starch having increased swelling power
02/14/2008WO2008017483A2 Spore surface displays of bioactive molecules
02/14/2008WO2008017234A1 Cell nuclear transfer method
02/14/2008WO2008017162A1 Oligonucleotides for discriminating related nucleic acid sequences
02/14/2008WO2007149896A3 Dna fragmentation assay
02/14/2008WO2007146767A8 Bacterial glutamine synthetases and methods of use
02/14/2008WO2007146427A3 Method for treating diabetic vascular complications
02/14/2008WO2007142954A3 Codon optimization method
02/14/2008WO2007141189A3 Plants having improved growth characteristics and method for making the same
02/14/2008WO2007135685A3 Compositions for silencing the expression of gibberellin 2-oxidase and uses thereof
02/14/2008WO2007132096A3 System for transposing hyperactive recombinant derivatives of mos-1 transposon
02/14/2008WO2007128757A3 Microbial intestinal delivery of obesity related peptides
02/14/2008WO2007111968A3 Promoter-based gene silencing
02/14/2008WO2007076537A3 Methods and compositions related to mutant kunitz domain i of tfpi-2
02/14/2008WO2007059715A8 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
02/14/2008WO2007058267A8 Novel protein and gene encoding the protein
02/14/2008WO2007052096A3 Production of bone morphogenic proteins (bmps) in transgenic mammals
02/14/2008WO2007047016A3 Methods for producing hybrid seed
02/14/2008WO2007031875A3 Modified antigen binding molecules with altered cell signaling activity
02/14/2008WO2007010283A8 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein
02/14/2008WO2005001065A3 Variant humicola grisea cbh1.1
02/14/2008WO2002042478A8 Nematode resistant plant
02/14/2008US20080040827 Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor
02/14/2008US20080040826 Stress Tolerant Transgenic Wheat Plant
02/14/2008US20080040825 Verticillium dahliae resistant plant; disease resistant crops
02/14/2008US20080040823 Novel Method Of Generating Non-Human Transgenic Animals, And Transgenic Animals Thus Obtained
02/14/2008US20080040822 Pufa polyketide synthase systems and uses thereof
02/14/2008US20080040820 Nonhuman Animals for Antibody Production, and Methods and Systems for Producing Anitbodies Using Such Animals
02/14/2008US20080039620 3'-End Nucleoside Unit Comprising Phosphoramidite
02/14/2008US20080039618 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
02/14/2008US20080039617 Short interfering RNA sequences for use in treatment and prevention of cell proliferative, diabetic and nervous system disorders
02/14/2008US20080039616 Tandem affinity purification systems and methods utilizing such systems
02/14/2008US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies
02/14/2008US20080039420 Method for inhibiting NOX1 gene expression
02/14/2008US20080039419 Integrin-linked kinase and its uses
02/14/2008US20080039418 Compositions and their uses directed to huntingtin
02/14/2008US20080039413 Novel compositions and methods in cancer
02/14/2008US20080039412 Short interfering RNA sequences for use in therapeutic, veterinary, agricultural, diagnostic, target validation, and genomic discovery applications
02/14/2008US20080039411 Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis
02/14/2008US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof
02/14/2008US20080039409 Method of Suppressing Cancer
02/14/2008US20080039402 Peptides and Peptidomimetics Binding to Cd23
02/14/2008US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression
02/14/2008US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants
02/14/2008US20080039392 CRAC channel and modulator screening methods
02/14/2008US20080039390 Use of the insulin-like-growth factor I splice variant MGF for the prevention of myocardial damage
02/14/2008US20080039386 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell
02/14/2008US20080039385 Neublastin Variants
02/14/2008US20080039382 Compositions related to pleiotrophin methods and uses thereof
02/14/2008US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same
02/14/2008US20080039343 Randomly Ordered Arrays and Methods of Making and Using
02/14/2008US20080039341 Unstructured recombinant polymers and uses thereof
02/14/2008US20080039338 Human antibodies as detection reagents
02/14/2008US20080039335 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants
02/14/2008US20080039328 Post Harvest Control of Genetically Modified Crop Growth Employing D-Amino Acid Compounds
02/14/2008US20080039326 Actin regulatory elements for use in plants